C12N 2795/10141
Use of virus, viral particle or viral elements as a vector
C12N2795/10141 (Use of virus, viral particle or viral elements as a vector) appears on 45 US grants and 73 published applications in this corpus.
Search patents in C12N- Granted patents
- 45
- Published applications
- 73
- Assignees
- 33
- Inventors
- 114
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 1 | 2 |
| 2012 | 0 | 1 |
| 2013 | 1 | 3 |
| 2014 | 3 | 3 |
| 2015 | 2 | 3 |
| 2016 | 4 | 4 |
| 2017 | 2 | 5 |
| 2018 | 1 | 1 |
| 2019 | 5 | 4 |
| 2020 | 0 | 6 |
| 2021 | 4 | 6 |
| 2022 | 1 | 11 |
| 2023 | 2 | 5 |
| 2024 | 5 | 2 |
| 2025 | 2 | 7 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2795/10143Viral genome or elements thereof as genetic vectorIndexing code33
- C12N 2795/10142Virus or viral particle as vehicleIndexing code13
- C12N 2795/10145Special targeting system for viral vectorsIndexing code2
- C12N 2795/10144Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
Recent patents
- Methods and systems for the rapid detection of Listeria using infectious agents28 Jul 2026US 12,692,482 B2Laboratory Corporation of America Holdings
- Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials21 Apr 2026US 12,606,834 B2North Carolina State University
- Chimeric proteins for selective lysis of bacteria23 Dec 2025US 12,502,419 B2Bactoclear Holdings PTE. Ltd
- Bacteriophage-based artificial viruses for human genome remodeling4 Mar 2025US 12,241,080 B2The Catholic University of America
- Methods and systems for the rapid detection of cronobacter using infectious agents19 Nov 2024US 12,146,182 B2Laboratory Corporation of America Holdings
- Targeting cells in stressed growing conditions1 Jan 2026US 2026/0002165 A1SNIPR Biome ApS
- Bacteria-targeting capsid particle, treatment composition, disinfectant, food, bacteria elimination method, bactericidal method, corrosion prevention method, animal treatment method, gene introduction method, bacteria function addition method, method for producing bacteria-targeting capsid particle, and method for producing nucleic acid for bacteria-targeting capsid particle25 Dec 2025US 2025/0387442 A1Jichi Medical University
- Synthetic viruses28 Aug 2025US 2025/0268963 A1SNIPR Biome ApS
- Bacteriophage7 Aug 2025US 2025/0249085 A1Glaxosmithkline Biologicals SA
- Targeting e coli cells26 Jun 2025US 2025/0205293 A1SNIPR Biome ApS
Most cited
By later US patents
- Ribonuclease resistant viral RNA standards180US 5,677,124 AAmbion, Inc. · 1997
- Ribonuclease resistant RNA preparation and utilization80US 5,939,262 AAmbion, Inc. · 1999
- Detection of listeria by means of recombinant bacteriophages45US 5,824,468 AMerck Patent Gesellschaft mit beschrankkter Haftung · 1998
- Ribonuclease resistant viral RNA standards43US 5,919,625 AAmbion, Inc. · 1999
- Methods of quantifying viral load in an animal with a ribonuclease resistant RNA preparation14US 6,399,307 B1Ambion, Inc. · 2002